Suchergebnisse - "Pneumonia, Viral"

PubPharm (276)

101

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) : Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)

enthalten in: ClinicalTrials.gov | 2021

102

A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia : A pragmatic adaptive randomized controlled Phase II/III multicenter study of IFX-1 in Patients with severe COVID-19 Pneumonia - PANAMO - Panamo

enthalten in: WHO International Clinical Trials Registry Platform | 2021

103

A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia : A pragmatic adaptive randomized controlled Phase II/III multicenter study of IFX-1 in Patients with severe COVID-19 Pneumonia - PANAMO - Panamo

enthalten in: WHO International Clinical Trials Registry Platform | 2021

104

Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection : Bruk av Ultralyd i Evaluering av Pasienter Med Mistenkt COVID-19 Infeksjon i Norge

enthalten in: ClinicalTrials.gov | 2021

105

A simple chest CT score for assessing the severity of pulmonary involvement in COVID-19

enthalten in: The Egyptian Journal of Radiology and Nuclear Medicine | 2021

von Abdel-Tawab, M. | Basha, M. | Mohamed, I. | +1

106

A simple chest CT score for assessing the severity of pulmonary involvement in COVID-19

enthalten in: The Egyptian Journal of Radiology and Nuclear Medicine | 2021

von Abdel-Tawab, M. | Basha, M. | Mohamed, I. | +1

107

Initial CT Findings and CO-RADS Stage in COVID-19 : Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients With PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives

enthalten in: ClinicalTrials.gov | 2021

108

A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19). : A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical trial of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia), in patients with coronavirus disease (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

109

Protective ventilation and outcomes of critically ill patients with COVID-19 : a cohort study

enthalten in: Annals of intensive care | 2021

von Ferreira, J. | Ho, Y. | Besen, B. | +89

110

Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study

enthalten in: Annals of intensive care | 2021

von Ferreira, J. | Ho, Y. | Besen, B. | +10